Risk Factors for Hearing Loss at Birth in Newborns With Congenital Cytomegalovirus Infection.


Journal

JAMA otolaryngology-- head & neck surgery
ISSN: 2168-619X
Titre abrégé: JAMA Otolaryngol Head Neck Surg
Pays: United States
ID NLM: 101589542

Informations de publication

Date de publication:
01 02 2023
Historique:
pmc-release: 29 12 2023
pubmed: 30 12 2022
medline: 14 2 2023
entrez: 29 12 2022
Statut: ppublish

Résumé

With a prevalence between 0.2% and 6.1% of all live births, congenital cytomegalovirus (cCMV) infection is a major cause of congenital nonhereditary sensorineural hearing loss. Despite the large amount of research on cCMV-related hearing loss, it is still unclear which newborns are at risk of hearing loss. To identify independent risk factors for cCMV-related congenital hearing loss and predictors of hearing loss severity at birth. This cross-sectional study of newborns with cCMV infection used data included in the Flemish CMV registry that was collected from 6 secondary and tertiary hospitals in Flanders, Belgium, over 15 years (January 1, 2007, to February 7, 2022). Data were analyzed March 3 to October 19, 2022. Patients were included in the study after confirmed diagnosis of cCMV infection and known hearing status at birth. Patients who presented with other possible causes of sensorineural hearing loss were excluded. Primary outcome was hearing status at birth. Clinical, neurological, and laboratory findings along with the timing of seroconversion and blood viral load were separately considered as risk factors. Binary logistic regression was performed to identify independent risk factors for congenital hearing loss in newborns with cCMV. Effect sizes were measured using Hedges g, odds ratio, or Cramer V. Of the 1033 newborns included in the study (553 of 1024 [54.0%] boys), 416 (40.3%) were diagnosed with symptomatic cCMV infection and 617 (59.7%) with asymptomatic cCMV infection. A total of 15.4% of the patients (n = 159) presented with congenital hearing loss; half of them (n = 80 [50.3%]) had isolated hearing loss. The regression model revealed 3 independent risk factors for congenital hearing loss: petechiae at birth (adjusted odds ratio [aOR], 6.7; 95% CI, 1.9-23.9), periventricular cysts on magnetic resonance imaging (MRI; aOR, 4.6; 95% CI, 1.5-14.1), and seroconversion in the first trimester (aOR, 3.1; 95% CI, 1.1-9.3). Lower viral loads were seen in patients with normal hearing compared with those with congenital hearing loss (median [IQR] viral load, 447.0 [39.3-2345.8] copies per milliliter of sample [copies/mL] vs 1349.5 [234.3-14 393.0] copies/mL; median difference, -397.0 [95% CI, -5058.0 to 174.0] copies/mL). Findings of this cross-sectional study suggest that newborns with cCMV infection and petechiae at birth, periventricular cysts on MRI, or a seroconversion in the first trimester had a higher risk of congenital hearing loss. Clinicians may use these risk factors to counsel parents in the prenatal and postnatal periods about the risk of congenital hearing loss. Moreover, linking clinical features to hearing loss may provide new insights into the pathogenesis of cCMV-related hearing loss. The importance of viral load as a risk factor for congenital hearing loss remains unclear.

Identifiants

pubmed: 36580312
pii: 2799844
doi: 10.1001/jamaoto.2022.4109
pmc: PMC9857716
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

122-130

Commentaires et corrections

Type : CommentIn

Auteurs

Elise De Cuyper (E)

Department of Head and Skin, Ghent University, Ghent, Belgium.
Department of Otorhinolaryngology, Ghent University Hospital, Ghent, Belgium.

Frederic Acke (F)

Department of Head and Skin, Ghent University, Ghent, Belgium.
Department of Otorhinolaryngology, Ghent University Hospital, Ghent, Belgium.

Annelies Keymeulen (A)

Department of Neonatal Intensive Care Unit, Ghent University Hospital, Ghent, Belgium.

Els M R De Leenheer (EMR)

Department of Head and Skin, Ghent University, Ghent, Belgium.
Department of Otorhinolaryngology, Ghent University Hospital, Ghent, Belgium.

Helen Van Hoecke (H)

Department of Head and Skin, Ghent University, Ghent, Belgium.
Department of Otorhinolaryngology, Ghent University Hospital, Ghent, Belgium.

Elizaveta Padalko (E)

Laboratory of Medical Microbiology, Ghent University Hospital, Ghent, Belgium.

An Boudewyns (A)

Faculty of Medicine and Translational Neurosciences, University of Antwerp, Antwerp, Belgium.
Department of Otorhinolaryngology and Head and Neck Surgery, Antwerp University Hospital, Antwerp, Belgium.

Annick Gilles (A)

Faculty of Medicine and Translational Neurosciences, University of Antwerp, Antwerp, Belgium.
Department of Otorhinolaryngology and Head and Neck Surgery, Antwerp University Hospital, Antwerp, Belgium.
Department of Education, Health and Social Work, University College Ghent, Ghent, Belgium.

Marie Muylle (M)

Department of Ear, Nose and Throat, Sint Jan Hospital, Bruges, Belgium.

Rudolf Kuhweide (R)

Department of Ear, Nose and Throat, Sint Jan Hospital, Bruges, Belgium.

Liesbeth Royackers (L)

Department of Otorhinolaryngology, Head and Neck Surgery, University Hospitals of Leuven, Leuven, Belgium.

Christian Desloovere (C)

Department of Otorhinolaryngology, Head and Neck Surgery, University Hospitals of Leuven, Leuven, Belgium.

Margriet Verstreken (M)

Department of Ear, Nose and Throat, GZA hospitals campus Sint Augustinus, Wilrijk, Belgium.

Isabelle Schatteman (I)

Department of Ear, Nose and Throat, GZA hospitals campus Sint Augustinus, Wilrijk, Belgium.

Ingeborg Dhooge (I)

Department of Head and Skin, Ghent University, Ghent, Belgium.
Department of Otorhinolaryngology, Ghent University Hospital, Ghent, Belgium.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH